CCPM
XGN icon

Cooper Creek Partners Management’s Exagen XGN Stock Holding History

Cooper Creek Partners Management’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-153,468
Closed -$1.23M – 143
2022
Q1 		$1.23M Buy
+153,468
New +$1.32M 0.13% 99

Other funds holding XGN

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Cooper Creek Partners Management's XGN Position: Q2 2022 in Review

Cooper Creek Partners Management sold out of Exagen (XGN) in Q2 2022, closing a stake of 153,468 shares — an estimated $1.23M sold.

Cooper Creek Partners Management first reported a position in XGN in Q1 2022 and held it in 1 quarter. The position peaked at $1.23M in Q1 2022. 47 funds tracked by Wall St. Rank hold XGN as of Q2 2022.

  • Cooper Creek Partners Management reported no remaining Exagen position as of Q2 2022 after selling out during the quarter.
  • Cooper Creek Partners Management sold 153,468 Exagen shares in Q2 2022, an estimated $1.23M.
  • Cooper Creek Partners Management first reported a position in Exagen in Q1 2022 and held it in 1 quarter.
  • Cooper Creek Partners Management's Exagen position peaked at $1.23M in Q1 2022.
  • 47 funds tracked by Wall St. Rank held Exagen as of Q2 2022.

Based on Cooper Creek Partners Management's 13F filing for Q2 2022, filed 15 Aug 2022.